Pluri
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pluri and other ETFs, options, and stocks.About PLUR
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
CEOYaky Yanay
CEOYaky Yanay
Employees127
Employees127
HeadquartersHaifa, Haifa
HeadquartersHaifa, Haifa
Founded2001
Founded2001
Employees127
Employees127
PLUR Key Statistics
Market cap27.39M
Market cap27.39M
Price-Earnings ratio-0.96
Price-Earnings ratio-0.96
Dividend yield—
Dividend yield—
Average volume53.61K
Average volume53.61K
High today—
High today—
Low today—
Low today—
Open price$3.00
Open price$3.00
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$2.88
52 Week low$2.88
Stock Snapshot
Pluri(PLUR) stock is priced at $3.06, giving the company a market capitalization of 27.39M. It carries a P/E multiple of -0.96.
On 2025-12-17, Pluri(PLUR) stock opened at $3.00, reached a high of —, and a low of —.
The Pluri(PLUR)'s current trading volume is 0, compared to an average daily volume of 53.61K.
During the past year, Pluri(PLUR) stock moved between $2.88 at its lowest and $7.13 at its peak.
During the past year, Pluri(PLUR) stock moved between $2.88 at its lowest and $7.13 at its peak.
People also own
Based on the portfolios of people who own PLUR. This list is generated using Robinhood data, and it’s not a recommendation.